Research ExplorerPublicationsSerum 25-hydroxyvitamin D and postmenopausal breast cancer s...

Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.

Standard

Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. / Vrieling, Alina; Hein, Rebecca; Abbas, Sascha; Schneeweiss, Andreas; Flesch-Janys, Dieter; Chang-Claude, Jenny.

In: BREAST CANCER RES, Vol. 13, No. 4, 4, 2011, p. 74.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Vrieling, A, Hein, R, Abbas, S, Schneeweiss, A, Flesch-Janys, D & Chang-Claude, J 2011, 'Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.', BREAST CANCER RES, vol. 13, no. 4, 4, pp. 74. https://doi.org/10.1186/bcr2920

APA

Vrieling, A., Hein, R., Abbas, S., Schneeweiss, A., Flesch-Janys, D., & Chang-Claude, J. (2011). Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. BREAST CANCER RES, 13(4), 74. [4]. https://doi.org/10.1186/bcr2920

Vancouver

Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. BREAST CANCER RES. 2011;13(4):74. 4. https://doi.org/10.1186/bcr2920

Bibtex

@article{a88a5eaad77443feb29aa262d5274f02,
title = "Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.",
abstract = "Vitamin D has been postulated to be involved in cancer prognosis. Thus far, only two studies reported on its association with recurrence and survival after breast cancer diagnosis yielding inconsistent results. Therefore, the aim of our study was to assess the effect of post-diagnostic serum 25-hydroxyvitamin D [25(OH)D] concentrations on overall survival and distant disease-free survival.",
author = "Alina Vrieling and Rebecca Hein and Sascha Abbas and Andreas Schneeweiss and Dieter Flesch-Janys and Jenny Chang-Claude",
year = "2011",
doi = "10.1186/bcr2920",
language = "English",
volume = "13",
pages = "74",
journal = "BREAST CANCER RES",
issn = "1465-5411",
publisher = "BioMed Central Ltd.",
number = "4",

}

RIS

TY - JOUR

T1 - Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.

AU - Vrieling, Alina

AU - Hein, Rebecca

AU - Abbas, Sascha

AU - Schneeweiss, Andreas

AU - Flesch-Janys, Dieter

AU - Chang-Claude, Jenny

PY - 2011

Y1 - 2011

N2 - Vitamin D has been postulated to be involved in cancer prognosis. Thus far, only two studies reported on its association with recurrence and survival after breast cancer diagnosis yielding inconsistent results. Therefore, the aim of our study was to assess the effect of post-diagnostic serum 25-hydroxyvitamin D [25(OH)D] concentrations on overall survival and distant disease-free survival.

AB - Vitamin D has been postulated to be involved in cancer prognosis. Thus far, only two studies reported on its association with recurrence and survival after breast cancer diagnosis yielding inconsistent results. Therefore, the aim of our study was to assess the effect of post-diagnostic serum 25-hydroxyvitamin D [25(OH)D] concentrations on overall survival and distant disease-free survival.

U2 - 10.1186/bcr2920

DO - 10.1186/bcr2920

M3 - SCORING: Journal article

VL - 13

SP - 74

JO - BREAST CANCER RES

JF - BREAST CANCER RES

SN - 1465-5411

IS - 4

M1 - 4

ER -